Concepedia

Novartis (Australia)

N(

Statistics

Publications

195

Citations

16.6K

Authors

12

Location

Preston, Australia

Novartis (Australia) is a company institution in Preston, Australia known for medicine, pharmacotherapy, and chronic myeloid leukemia therapy.

HomepageWikipediaROR

Top concepts

Publications

195

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

David M. Ross, Susan Branford, John F. Seymour et al. · Blood · 2013 · 706 citations

, , +11

High frequency of point mutations clustered within the adenosine triphosphate–binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance

Susan Branford, Zbigniew Rudzki, Sonya Walsh et al. · Blood · 2002 · 657 citations · Full text

, , +14

OCT-1–mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib

Deborah L. White, Verity A Saunders, Phuong Dang et al. · Blood · 2006 · 432 citations · Full text

, , +6

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

Susan Branford, Linda Fletcher, Nicholas C.P. Cross et al. · Blood · 2008 · 389 citations · Full text

, , +9

Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity

Deborah L. White, Verity A Saunders, Phuong Dang et al. · Blood · 2007 · 331 citations

, , +2

1–5 of 195

Authors

12

  1. MC
    Michael Copeman

    Novartis (Australia), Australia

    40 publications · 307 citations

    11

    h-index

  2. NK
    Nicol Kurstjens

    Novartis (Australia), Australia

    36 publications · 474 citations

    9

    h-index

  3. LH
    Lilie Herawati

    Novartis (Australia), Australia

    5 publications · 86 citations

    4

    h-index

  4. CH
    Carla H. Swemmer

    Novartis (Australia), Australia

    5 publications · 37 citations

    4

    h-index

  5. RT
    Robert Traficante

    Novartis (Australia), Australia

    8 publications · 72 citations

    4

    h-index

1–5 of 12